机译:评估2型糖尿病的筛查和早期检测策略以及糖耐量减低(DETECT-2)更新芬兰糖尿病风险评分以预测2型糖尿病的发生
Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands;
Steno Diabetes Center A/S, Gentofte, Denmark;
Department of Methodology and Applied Biostatistics, Institute of Health Sciences, VU University, Amsterdam, the Netherlands;
Department of General Practice and the EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands;
Research Centre for Prevention and Health, The Capital Region of Denmark, Glostrup, Denmark;
Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia;
Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia;
Department of Public Health and Clinical Medicine, Umeå University, Umeå and Sundyby Hospital, Luleå, Sweden;
1st Department of Internal Medicine, Semmelweis University Faculty of Medicine, Buda;
Epidemiology; Incidence; Prediction model; Primary prevention; Type 2 diabetes;
机译:评估芬兰糖尿病风险评分,作为空腹血糖受损,葡萄糖耐量受损和未发现糖尿病的筛查工具。
机译:菲律宾未诊断的2型糖尿病患者的芬兰糖尿病风险评分,改良的芬兰糖尿病风险评分和简化的芬兰糖尿病风险评分的基于社区的横截面筛查
机译:使用糖尿病风险评分进行机会性筛查未诊断的糖尿病和糖耐量减低的患者:IGLOO(糖耐量减低和长期观察结果)研究。
机译:2型糖尿病风险因子预测得分与妊娠第二和第三三个月的血糖水平相关
机译:美洲印第安人的体育活动和饮食中饱和脂肪摄入与2型糖尿病和空腹血糖受损的关联:强心家庭研究
机译:在西班牙马德里基于社区的筛查未诊断出的2型糖尿病和血糖异常的社区计划中芬兰糖尿病风险评分和简化的芬兰糖尿病风险评分的表现:SPREDIA-2研究
机译:评估2型糖尿病的筛查和早期检测策略以及糖耐量减低(DETECT-2)更新芬兰糖尿病风险评分以预测2型糖尿病的发病率